FDAClass IISeptember 11, 2024

Semaglutide / Cyanocobalamin Injection: 2.5/0.5 mg/mL recall: Sterility Concern

Semaglutide / Cyanocobalamin Injection: 2.5/0.5 mg/mL, 2 mL Multiple Dose Vial, Compounded Rx Product, ProRX 267-565-7008, NDC 84139-225-02

Why was Semaglutide / Cyanocobalamin Injection: 2.5/0.5 mg/mL recalled?

Lack of Assurance of Sterility

What should I do if I have this product?

The recall is ongoing. Follow the firm and FDA instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot # ProRx031924-1, BUD 09/18/2024

Product
Semaglutide / Cyanocobalamin Injection: 2.5/0.5 mg/mL, 2 mL Multiple Dose Vial, Compounded Rx Product, ProRX 267-565-7008, NDC 84139-225-02
Recalling firm
ProRx LLC
Quantity
500 vials
Distribution
Nationwide in the USA
Recall date
September 11, 2024
Classification
Class II
Status
Ongoing
Agency
FDA (drug)
Open FDA enforcement record Latest recalls